Spire Wealth Management Has $4.35 Million Position in Colgate-Palmolive (NYSE:CL)

Spire Wealth Management raised its position in Colgate-Palmolive (NYSE:CLFree Report) by 835.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 61,113 shares of the company’s stock after purchasing an additional 54,578 shares during the quarter. Spire Wealth Management’s holdings in Colgate-Palmolive were worth $4,346,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of CL. Dimensional Fund Advisors LP raised its position in Colgate-Palmolive by 4.0% in the first quarter. Dimensional Fund Advisors LP now owns 2,444,508 shares of the company’s stock valued at $185,376,000 after purchasing an additional 94,837 shares during the last quarter. Covestor Ltd increased its stake in shares of Colgate-Palmolive by 71.9% in the first quarter. Covestor Ltd now owns 2,451 shares of the company’s stock valued at $186,000 after buying an additional 1,025 shares during the period. Mackenzie Financial Corp increased its stake in shares of Colgate-Palmolive by 8.5% in the first quarter. Mackenzie Financial Corp now owns 1,882,813 shares of the company’s stock valued at $142,774,000 after buying an additional 146,936 shares during the period. First Western Trust Bank acquired a new stake in shares of Colgate-Palmolive in the first quarter valued at about $569,000. Finally, Wsfs Capital Management LLC acquired a new stake in shares of Colgate-Palmolive in the first quarter valued at about $288,000. 78.36% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on CL shares. Bank of America raised Colgate-Palmolive from a “neutral” rating to a “buy” rating and set a $90.00 price target for the company in a research note on Friday, December 15th. Stifel Nicolaus raised Colgate-Palmolive from a “hold” rating to a “buy” rating and decreased their price target for the company from $85.00 to $81.00 in a research note on Monday, October 16th. Raymond James raised Colgate-Palmolive from a “market perform” rating to an “outperform” rating and set a $91.00 price target for the company in a research note on Monday, January 29th. Royal Bank of Canada increased their price target on Colgate-Palmolive from $79.00 to $80.00 and gave the company a “sector perform” rating in a research note on Monday, October 30th. Finally, Sanford C. Bernstein decreased their price target on Colgate-Palmolive from $82.00 to $76.00 in a research note on Thursday, October 12th. Three investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. According to MarketBeat.com, Colgate-Palmolive currently has an average rating of “Moderate Buy” and a consensus price target of $86.93.

View Our Latest Stock Analysis on Colgate-Palmolive

Insider Activity

In other news, EVP Gregory Malcolm sold 8,930 shares of the firm’s stock in a transaction that occurred on Thursday, February 1st. The stock was sold at an average price of $85.35, for a total value of $762,175.50. Following the transaction, the executive vice president now owns 8,043 shares in the company, valued at $686,470.05. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, EVP Gregory Malcolm sold 8,930 shares of the firm’s stock in a transaction that occurred on Thursday, February 1st. The stock was sold at an average price of $85.35, for a total value of $762,175.50. Following the transaction, the executive vice president now owns 8,043 shares in the company, valued at $686,470.05. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Jennifer Daniels sold 61,633 shares of the firm’s stock in a transaction that occurred on Thursday, February 1st. The shares were sold at an average price of $83.93, for a total value of $5,172,857.69. Following the completion of the transaction, the insider now owns 57,948 shares in the company, valued at approximately $4,863,575.64. The disclosure for this sale can be found here. Insiders have sold 92,123 shares of company stock worth $7,635,941 over the last 90 days. 0.34% of the stock is currently owned by corporate insiders.

Colgate-Palmolive Trading Down 1.7 %

Shares of Colgate-Palmolive stock opened at $84.62 on Monday. The company has a debt-to-equity ratio of 21.40, a quick ratio of 0.26 and a current ratio of 0.41. Colgate-Palmolive has a 52 week low of $67.62 and a 52 week high of $86.14. The stock has a 50 day moving average price of $79.80 and a two-hundred day moving average price of $76.05. The stock has a market capitalization of $69.67 billion, a PE ratio of 30.44, a price-to-earnings-growth ratio of 3.72 and a beta of 0.42.

Colgate-Palmolive (NYSE:CLGet Free Report) last announced its quarterly earnings data on Friday, January 26th. The company reported $0.87 EPS for the quarter, beating analysts’ consensus estimates of $0.85 by $0.02. Colgate-Palmolive had a return on equity of 509.75% and a net margin of 11.82%. The firm had revenue of $4.95 billion during the quarter, compared to analysts’ expectations of $4.89 billion. During the same quarter last year, the firm posted $0.77 earnings per share. The company’s revenue for the quarter was up 6.9% compared to the same quarter last year. As a group, equities analysts anticipate that Colgate-Palmolive will post 3.48 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, February 15th. Shareholders of record on Monday, January 22nd will be paid a $0.48 dividend. The ex-dividend date of this dividend is Friday, January 19th. This represents a $1.92 dividend on an annualized basis and a yield of 2.27%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 69.06%.

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Recommended Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.